microarray glass slide with dapi Search Results


99
Thermo Fisher microarray glass slide with dapi
Microarray Glass Slide With Dapi, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray glass slide with dapi/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
microarray glass slide with dapi - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

98
Vector Laboratories vectashield antifade mounting medium with dapi
Vectashield Antifade Mounting Medium With Dapi, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield antifade mounting medium with dapi/product/Vector Laboratories
Average 98 stars, based on 1 article reviews
vectashield antifade mounting medium with dapi - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

86
Thermo Fisher prolong diamond antifademountant with dapi
Prolong Diamond Antifademountant With Dapi, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prolong diamond antifademountant with dapi/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
prolong diamond antifademountant with dapi - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

96
SouthernBiotech dapi fluoromount g
Methodology for preparing, seeding, and analyzing microarrays. a) 1 kPa and 6kPa PA solutions are prepared as described in 2.2. b) Slides are washed, etched, and silanized before prepolymer solution is deposited in the printing region of interest and cured and dehydrated. c) ECM combinations are diluted in printing buffer to a final concentration of 250 μg/mL and arrayed onto the slide(s) with a liquid handler. d) 200,000 cells per microarray were seeded in monoculture or coculture and incubated for 30 minutes. e) Microarrays were washed with PBS and then incubated for 24 hours at which point f) microarrays were fixed in 4% PFA and stained with phalloidin and <t>DAPI</t> with fluoromount. g) Fixed and mounted slides were imaged on the Zeiss AxioScan.Z1. h) Images were exported and cropped into identified islands using MATLAB. CellProfiler was used to identify fluorescent regions of the cell (nuclei, actin) and partition information including cell count, cell area, etc. i) The outputs of cell profiler are then analyzed in R Studio.
Dapi Fluoromount G, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi fluoromount g/product/SouthernBiotech
Average 96 stars, based on 1 article reviews
dapi fluoromount g - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Thermo Fisher antifade mountant dapi
Methodology for preparing, seeding, and analyzing microarrays. a) 1 kPa and 6kPa PA solutions are prepared as described in 2.2. b) Slides are washed, etched, and silanized before prepolymer solution is deposited in the printing region of interest and cured and dehydrated. c) ECM combinations are diluted in printing buffer to a final concentration of 250 μg/mL and arrayed onto the slide(s) with a liquid handler. d) 200,000 cells per microarray were seeded in monoculture or coculture and incubated for 30 minutes. e) Microarrays were washed with PBS and then incubated for 24 hours at which point f) microarrays were fixed in 4% PFA and stained with phalloidin and <t>DAPI</t> with fluoromount. g) Fixed and mounted slides were imaged on the Zeiss AxioScan.Z1. h) Images were exported and cropped into identified islands using MATLAB. CellProfiler was used to identify fluorescent regions of the cell (nuclei, actin) and partition information including cell count, cell area, etc. i) The outputs of cell profiler are then analyzed in R Studio.
Antifade Mountant Dapi, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antifade mountant dapi/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
antifade mountant dapi - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Thermo Fisher dapi
KEY RESOURCES TABLE
Dapi, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
dapi - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Agilent technologies mirna labeling reagent hybridization kits
KEY RESOURCES TABLE
Mirna Labeling Reagent Hybridization Kits, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mirna labeling reagent hybridization kits/product/Agilent technologies
Average 90 stars, based on 1 article reviews
mirna labeling reagent hybridization kits - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abbott Laboratories ccdcamera–basedgenosensor reader system
KEY RESOURCES TABLE
Ccdcamera–Basedgenosensor Reader System, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ccdcamera–basedgenosensor reader system/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
ccdcamera–basedgenosensor reader system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies human mir microarray kits
KEY RESOURCES TABLE
Human Mir Microarray Kits, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mir microarray kits/product/Agilent technologies
Average 90 stars, based on 1 article reviews
human mir microarray kits - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biomax Inc human prostate tissue sections
(A) Box and whisker graph showing mRNA level in Fragments per Kilobase of transcript per million mapped reads (FPKM) of Ate1 in primary tumors from patients with metastatic or non-metastatic status in comparison to normal <t>prostate</t> <t>tissue.</t> The data for mRNA were retrieved from the TCGA-PRAD dataset as well as the Beltran dataset . The mRNA levels were assessed by RNA sequencing in these databases. See for additional information on the normalization protocol. (B) Analysis of dataset of RNA level examined by microarray in excised primary prostate cancer tissue mRNA that had up to 5 years of patient follow-up after time of radical prostatectomy . Samples were separated into groups by patient outcome (metastatic or not) to determine the relationship between future metastatic outcome and the Ate1 mRNA levels in the primary tumors. (C) Quantification of Ate1 protein levels on <t>human</t> primary prostate tumor sites by immunohistochemistry, with DAPI staining for loading normalization with DNA. The analysis was performed on human prostate cancer arrays containing primary prostate tumors with either metastatic or non-metastatic outcome, as well as normal (non-diseased) prostate tissues. The samples were separately grouped by the patient outcome (metastatic or non-metastatic) for analysis. (D) Protein level of Ate1 in tissue samples from C were further stratified by Gleason Score and metastatic outcomes. See also for representative images. (E) A representative Western blot showing protein levels of Ate1 in multiple human prostate cancer cell lines, including androgen-dependent and indolent cell line LNCaP, its castration-resistant derivative LNCaP c4–2b cells, castration-resistant and intermediate aggressive cell lines DU145 and PC3, and the castration-resistant and highly aggressive PC3-ML, a derivative of PC3. Actin was used as a loading control. The graph shows the quantification from 3 independent repeats, showing a trend of reduced Ate1 correlating with cell line progression and aggressive phenotypes. Statistical significance was assessed with two-tailed Mann-Whitney U test for the human samples, and with the Student’s t-test for cell-based data. * = p<0.05, ** = p<0.01, *** = p<0.001. The monoclonal Ate1 antibody (clone 6F11, Millipore) used in this study has been shown to be highly specific for Western blot and IHC( , ). See also for additional data demonstrating the specificity of this antibody.
Human Prostate Tissue Sections, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human prostate tissue sections/product/Biomax Inc
Average 90 stars, based on 1 article reviews
human prostate tissue sections - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nikon e800 fluorescence microscope
(A) Box and whisker graph showing mRNA level in Fragments per Kilobase of transcript per million mapped reads (FPKM) of Ate1 in primary tumors from patients with metastatic or non-metastatic status in comparison to normal <t>prostate</t> <t>tissue.</t> The data for mRNA were retrieved from the TCGA-PRAD dataset as well as the Beltran dataset . The mRNA levels were assessed by RNA sequencing in these databases. See for additional information on the normalization protocol. (B) Analysis of dataset of RNA level examined by microarray in excised primary prostate cancer tissue mRNA that had up to 5 years of patient follow-up after time of radical prostatectomy . Samples were separated into groups by patient outcome (metastatic or not) to determine the relationship between future metastatic outcome and the Ate1 mRNA levels in the primary tumors. (C) Quantification of Ate1 protein levels on <t>human</t> primary prostate tumor sites by immunohistochemistry, with DAPI staining for loading normalization with DNA. The analysis was performed on human prostate cancer arrays containing primary prostate tumors with either metastatic or non-metastatic outcome, as well as normal (non-diseased) prostate tissues. The samples were separately grouped by the patient outcome (metastatic or non-metastatic) for analysis. (D) Protein level of Ate1 in tissue samples from C were further stratified by Gleason Score and metastatic outcomes. See also for representative images. (E) A representative Western blot showing protein levels of Ate1 in multiple human prostate cancer cell lines, including androgen-dependent and indolent cell line LNCaP, its castration-resistant derivative LNCaP c4–2b cells, castration-resistant and intermediate aggressive cell lines DU145 and PC3, and the castration-resistant and highly aggressive PC3-ML, a derivative of PC3. Actin was used as a loading control. The graph shows the quantification from 3 independent repeats, showing a trend of reduced Ate1 correlating with cell line progression and aggressive phenotypes. Statistical significance was assessed with two-tailed Mann-Whitney U test for the human samples, and with the Student’s t-test for cell-based data. * = p<0.05, ** = p<0.01, *** = p<0.001. The monoclonal Ate1 antibody (clone 6F11, Millipore) used in this study has been shown to be highly specific for Western blot and IHC( , ). See also for additional data demonstrating the specificity of this antibody.
E800 Fluorescence Microscope, supplied by Nikon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e800 fluorescence microscope/product/Nikon
Average 90 stars, based on 1 article reviews
e800 fluorescence microscope - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Photometrix Imaging coolsnap ccd camera
(A) Box and whisker graph showing mRNA level in Fragments per Kilobase of transcript per million mapped reads (FPKM) of Ate1 in primary tumors from patients with metastatic or non-metastatic status in comparison to normal <t>prostate</t> <t>tissue.</t> The data for mRNA were retrieved from the TCGA-PRAD dataset as well as the Beltran dataset . The mRNA levels were assessed by RNA sequencing in these databases. See for additional information on the normalization protocol. (B) Analysis of dataset of RNA level examined by microarray in excised primary prostate cancer tissue mRNA that had up to 5 years of patient follow-up after time of radical prostatectomy . Samples were separated into groups by patient outcome (metastatic or not) to determine the relationship between future metastatic outcome and the Ate1 mRNA levels in the primary tumors. (C) Quantification of Ate1 protein levels on <t>human</t> primary prostate tumor sites by immunohistochemistry, with DAPI staining for loading normalization with DNA. The analysis was performed on human prostate cancer arrays containing primary prostate tumors with either metastatic or non-metastatic outcome, as well as normal (non-diseased) prostate tissues. The samples were separately grouped by the patient outcome (metastatic or non-metastatic) for analysis. (D) Protein level of Ate1 in tissue samples from C were further stratified by Gleason Score and metastatic outcomes. See also for representative images. (E) A representative Western blot showing protein levels of Ate1 in multiple human prostate cancer cell lines, including androgen-dependent and indolent cell line LNCaP, its castration-resistant derivative LNCaP c4–2b cells, castration-resistant and intermediate aggressive cell lines DU145 and PC3, and the castration-resistant and highly aggressive PC3-ML, a derivative of PC3. Actin was used as a loading control. The graph shows the quantification from 3 independent repeats, showing a trend of reduced Ate1 correlating with cell line progression and aggressive phenotypes. Statistical significance was assessed with two-tailed Mann-Whitney U test for the human samples, and with the Student’s t-test for cell-based data. * = p<0.05, ** = p<0.01, *** = p<0.001. The monoclonal Ate1 antibody (clone 6F11, Millipore) used in this study has been shown to be highly specific for Western blot and IHC( , ). See also for additional data demonstrating the specificity of this antibody.
Coolsnap Ccd Camera, supplied by Photometrix Imaging, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/coolsnap ccd camera/product/Photometrix Imaging
Average 90 stars, based on 1 article reviews
coolsnap ccd camera - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Methodology for preparing, seeding, and analyzing microarrays. a) 1 kPa and 6kPa PA solutions are prepared as described in 2.2. b) Slides are washed, etched, and silanized before prepolymer solution is deposited in the printing region of interest and cured and dehydrated. c) ECM combinations are diluted in printing buffer to a final concentration of 250 μg/mL and arrayed onto the slide(s) with a liquid handler. d) 200,000 cells per microarray were seeded in monoculture or coculture and incubated for 30 minutes. e) Microarrays were washed with PBS and then incubated for 24 hours at which point f) microarrays were fixed in 4% PFA and stained with phalloidin and DAPI with fluoromount. g) Fixed and mounted slides were imaged on the Zeiss AxioScan.Z1. h) Images were exported and cropped into identified islands using MATLAB. CellProfiler was used to identify fluorescent regions of the cell (nuclei, actin) and partition information including cell count, cell area, etc. i) The outputs of cell profiler are then analyzed in R Studio.

Journal: bioRxiv

Article Title: Matrix tropism influences endometriotic cell attachment patterns

doi: 10.1101/2025.02.22.639314

Figure Lengend Snippet: Methodology for preparing, seeding, and analyzing microarrays. a) 1 kPa and 6kPa PA solutions are prepared as described in 2.2. b) Slides are washed, etched, and silanized before prepolymer solution is deposited in the printing region of interest and cured and dehydrated. c) ECM combinations are diluted in printing buffer to a final concentration of 250 μg/mL and arrayed onto the slide(s) with a liquid handler. d) 200,000 cells per microarray were seeded in monoculture or coculture and incubated for 30 minutes. e) Microarrays were washed with PBS and then incubated for 24 hours at which point f) microarrays were fixed in 4% PFA and stained with phalloidin and DAPI with fluoromount. g) Fixed and mounted slides were imaged on the Zeiss AxioScan.Z1. h) Images were exported and cropped into identified islands using MATLAB. CellProfiler was used to identify fluorescent regions of the cell (nuclei, actin) and partition information including cell count, cell area, etc. i) The outputs of cell profiler are then analyzed in R Studio.

Article Snippet: After the washes, the PBS was removed from the slides, 100 μL of DAPI Fluoromount-G (SouthernBiotech, 0100-20) solution was added on top of the microarrays and sandwiched with a coverslip (Electron Microscopy Sciences, 63765-01), sealed with clear nail polish, and stored protected from light at 4°C until imaging.

Techniques: Concentration Assay, Microarray, Incubation, Staining, Cell Counting

KEY RESOURCES TABLE

Journal: Cell

Article Title: FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells

doi: 10.1016/j.cell.2020.11.042

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: After 3 × 10 min washes with KCMT buffer, cells were stained with DAPI (Thermo Fisher Scientific no. D1306), coverslips mounted with anti-fade mounting medium (Vector Laboratories no. H-1000), and slides examined by fluorescence microscopy (Nikon Inverted TE300) or confocal microscopy (Zeiss LSM 710 NLO).

Techniques: Marker, Microarray, Recombinant, Plasmid Preparation, Imaging, Staining, Immunoprecipitation, Cell Isolation, Software

(A) Box and whisker graph showing mRNA level in Fragments per Kilobase of transcript per million mapped reads (FPKM) of Ate1 in primary tumors from patients with metastatic or non-metastatic status in comparison to normal prostate tissue. The data for mRNA were retrieved from the TCGA-PRAD dataset as well as the Beltran dataset . The mRNA levels were assessed by RNA sequencing in these databases. See for additional information on the normalization protocol. (B) Analysis of dataset of RNA level examined by microarray in excised primary prostate cancer tissue mRNA that had up to 5 years of patient follow-up after time of radical prostatectomy . Samples were separated into groups by patient outcome (metastatic or not) to determine the relationship between future metastatic outcome and the Ate1 mRNA levels in the primary tumors. (C) Quantification of Ate1 protein levels on human primary prostate tumor sites by immunohistochemistry, with DAPI staining for loading normalization with DNA. The analysis was performed on human prostate cancer arrays containing primary prostate tumors with either metastatic or non-metastatic outcome, as well as normal (non-diseased) prostate tissues. The samples were separately grouped by the patient outcome (metastatic or non-metastatic) for analysis. (D) Protein level of Ate1 in tissue samples from C were further stratified by Gleason Score and metastatic outcomes. See also for representative images. (E) A representative Western blot showing protein levels of Ate1 in multiple human prostate cancer cell lines, including androgen-dependent and indolent cell line LNCaP, its castration-resistant derivative LNCaP c4–2b cells, castration-resistant and intermediate aggressive cell lines DU145 and PC3, and the castration-resistant and highly aggressive PC3-ML, a derivative of PC3. Actin was used as a loading control. The graph shows the quantification from 3 independent repeats, showing a trend of reduced Ate1 correlating with cell line progression and aggressive phenotypes. Statistical significance was assessed with two-tailed Mann-Whitney U test for the human samples, and with the Student’s t-test for cell-based data. * = p<0.05, ** = p<0.01, *** = p<0.001. The monoclonal Ate1 antibody (clone 6F11, Millipore) used in this study has been shown to be highly specific for Western blot and IHC( , ). See also for additional data demonstrating the specificity of this antibody.

Journal: Oncogene

Article Title: Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis

doi: 10.1038/s41388-018-0462-2

Figure Lengend Snippet: (A) Box and whisker graph showing mRNA level in Fragments per Kilobase of transcript per million mapped reads (FPKM) of Ate1 in primary tumors from patients with metastatic or non-metastatic status in comparison to normal prostate tissue. The data for mRNA were retrieved from the TCGA-PRAD dataset as well as the Beltran dataset . The mRNA levels were assessed by RNA sequencing in these databases. See for additional information on the normalization protocol. (B) Analysis of dataset of RNA level examined by microarray in excised primary prostate cancer tissue mRNA that had up to 5 years of patient follow-up after time of radical prostatectomy . Samples were separated into groups by patient outcome (metastatic or not) to determine the relationship between future metastatic outcome and the Ate1 mRNA levels in the primary tumors. (C) Quantification of Ate1 protein levels on human primary prostate tumor sites by immunohistochemistry, with DAPI staining for loading normalization with DNA. The analysis was performed on human prostate cancer arrays containing primary prostate tumors with either metastatic or non-metastatic outcome, as well as normal (non-diseased) prostate tissues. The samples were separately grouped by the patient outcome (metastatic or non-metastatic) for analysis. (D) Protein level of Ate1 in tissue samples from C were further stratified by Gleason Score and metastatic outcomes. See also for representative images. (E) A representative Western blot showing protein levels of Ate1 in multiple human prostate cancer cell lines, including androgen-dependent and indolent cell line LNCaP, its castration-resistant derivative LNCaP c4–2b cells, castration-resistant and intermediate aggressive cell lines DU145 and PC3, and the castration-resistant and highly aggressive PC3-ML, a derivative of PC3. Actin was used as a loading control. The graph shows the quantification from 3 independent repeats, showing a trend of reduced Ate1 correlating with cell line progression and aggressive phenotypes. Statistical significance was assessed with two-tailed Mann-Whitney U test for the human samples, and with the Student’s t-test for cell-based data. * = p<0.05, ** = p<0.01, *** = p<0.001. The monoclonal Ate1 antibody (clone 6F11, Millipore) used in this study has been shown to be highly specific for Western blot and IHC( , ). See also for additional data demonstrating the specificity of this antibody.

Article Snippet: Slides containing human prostate tissue sections (Biomax, Derwood, US) was stained with monoclonal rat anti-Ate1 (Clone 6F11; Millipore #MABS436) and DAPI.

Techniques: Whisker Assay, Comparison, RNA Sequencing, Microarray, Immunohistochemistry, Staining, Western Blot, Control, Two Tailed Test, MANN-WHITNEY